candesartan and epidermal growth factor

candesartan has been researched along with epidermal growth factor in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Düsing, R; el-Haschimi, K; Ko, Y; Sachinidis, A; Seul, C; Vetter, H	1

Other Studies

1 other study(ies) available for candesartan and epidermal growth factor

Article	Year
CV-11974, the active metabolite of TCV-116 (Candesarten), inhibits the synergistic or additive effect of different growth factors on angiotensin II-induced proliferation of vascular smooth muscle cells. Biochemical pharmacology, 1996, Jul-12, Volume: 52, Issue:1 Topics: Angiotensin II; Animals; Antihypertensive Agents; Becaplermin; Benzimidazoles; Biphenyl Compounds; Cell Division; Cells, Cultured; Drug Synergism; Epidermal Growth Factor; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Rats; Rats, Inbred WKY; Tetrazoles	1996

Article

Year

CV-11974, the active metabolite of TCV-116 (Candesarten), inhibits the synergistic or additive effect of different growth factors on angiotensin II-induced proliferation of vascular smooth muscle cells.

Biochemical pharmacology, 1996, Jul-12, Volume: 52, Issue:1

Topics: Angiotensin II; Animals; Antihypertensive Agents; Becaplermin; Benzimidazoles; Biphenyl Compounds; Cell Division; Cells, Cultured; Drug Synergism; Epidermal Growth Factor; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Rats; Rats, Inbred WKY; Tetrazoles

1996